Preemptive Versus Reactive Topical Clobetasol for Regorafenib‐Induced Hand‐Foot Reactions: A Preplanned Analysis of the ReDOS Trial

BACKGROUND: Hand‐foot skin reaction (HFSR) is the most common regorafenib‐induced adverse event and is in need of effective prevention and palliation. MATERIALS AND METHODS: The Regorafenib Dose Optimization Study (ReDOS), a four‐arm, previously published trial with a 1:1:1:1 randomization scheme, w...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncologist
Egile Nagusiak: Jatoi, Aminah, Ou, Fang‐Shu, Ahn, Daniel H., Zemla, Tyler J., Le‐Rademacher, Jennifer G., Boland, Patrick, Ciombor, Kristen K., Jacobs, Nisha L., Pasche, Boris, Cleary, James M., McCune, Jeannine S., Pedersen, Katrina S., Barzi, Afsaneh, Chiorean, E. Gabriela, Heying, Erica N., Lenz, Heinz‐Josef, Sloan, Jeff A., Grothey, Axel, Lacouture, Mario E., Bekaii‐Saab, Tanios
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Inc. 2021
Gaiak:
Symptom Management and Supportive Care
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265366/
https://ncbi.nlm.nih.gov/pubmed/33604969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13730
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak